Key statistics
On Tuesday, Biohaven Ltd (BHVN:NYQ) closed at 12.20, 63.10% above the 52 week low of 7.48 set on Nov 11, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.00 |
|---|---|
| High | 13.08 |
| Low | 12.11 |
| Bid | 12.22 |
| Offer | 12.48 |
| Previous close | 12.78 |
| Average volume | 2.41m |
|---|---|
| Shares outstanding | 132.64m |
| Free float | 120.01m |
| P/E (TTM) | -- |
| Market cap | 1.70bn USD |
| EPS (TTM) | -7.60 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Press releases
- Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
- Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026
- Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder
- Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress
- Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M
More ▼
